Introduction
Organ transplantation has become the treatment of choice for end-stage organ failure. While in the early years acute rejections were a major cause for graft loss, with the introduction of calcineurin inhibitors (CNI) acute rejection episodes became clinically manageable and resulted in an overall improved 1-year graft survival [1] . Despite this improvement, chronic transplant loss was not positively affected by CNI; use of CNI was rather recognized as a risk factor for chronic graft loss based on several adverse effects [2, 3] . Particularly in cardiac allografts, chronic graft loss is accompanied by transplant vasculopathy (TV) [4] which is characterized by intimal thickening, medial smooth muscle cell (SMC) apoptosis and intimal SMC proliferation. Even though much scientifi c efforts have been put in prevention of TV, there is no adequate treatment currently available [5] and thus prevention of TV remains a scientifi c challenge in transplantat medicine.
Damage of the endothelium is now well recognized as an important initial step in the development of TV. Both immunological and non-immunologic factors contribute to vascular damage which may occur as a consequence of organ preservation, ischemia/reperfusion (I/R), (subclinical) cellular and humoral rejection episodes and virus infections. Also the traditional cardiac risk factors, e.g. dyslipidemia and hypertension, may cause endothelial cell injury [6] .
Irrespective of the cause of endothelial damage, leukocytes are mostly recruited to these sites of damage and infi ltrate into the subendothelial space causing vascular infl ammation [7, 8] . Platelets may become activated at these sites and start to release procoagulant and proinfl ammatory factors thereby perpetuating infl ammation [9, 10] and recruitment of progenitor cells [11, 12] . In addition, several studies clearly showed a positive correlation between endothelial injury and progenitor cell recruitment [13] . It is believed that the hematopoietic progenitor cells proliferate in situ, dedifferentiate into smooth muscle-like cells and secrete extracellular matrix proteins which form a neointima (NI) [14] [15] [16] [17] [18] [19] . Infi ltrated alloreactive T cells are also involved in TV as they may cause medial SMC apoptosis via production of TNF-α or INF-γ [20] [21] [22] [23] . Both cytokines will further activate surrounding endothelial cells with subsequent leukocyte recruitment and platelet activation. Therefore, strategies that aim to break this vicious cycle hold the promise of preventing TV. Indeed it has been shown that platelet inhibition results in improved glomerular fi ltration rates (GFR) after 2 years of treatment of renal allograft recipients [24] . Other experimentally effective strategies that have shown to affect TV are amongst others based on limiting leukocyte recruitment [25] , inhibition of intimal smooth muscle cell proliferation [26] or transcriptional inhibition of infl ammatory mediators [27] .
In a prospective randomized multicenter trial we have shown that donor treatment with low-dose dopamine has a salutary effect on immediate kidney graft function [28] . In a subgroup analysis this was translated into a better graft survival for recipients who obtained a renal allograft with prolonged cold preservation time.
Graft survival was also improved in heart allograft recipients [29] but did not affect outcome after liver transplantation [28] . Based on in vitro experiments, we have postulated that the protective effect of dopamine is independent of its hemodynamic action and requires the redox active catechol structure [30] . Moreover, we have shown that conjugation of n-octanoic acid to the amine side chain of dopamine, which likely impairs adrenergic and dopaminergic receptor engagement, results in a far more protective compound [31] . N-octanoyl-dopamine (NOD) not only protects cells and tissues against prolonged hypothermic preservation [31] , it also strongly inhibits platelet function ex vivo [32] , prevents NF-κB activation in vitro [33] and inhibits T cell activation and proliferation [34] . In vivo, we showed that NOD also mitigates ischemia-induced acute kidney injury [35] . In keeping with the notion that the endothelium, platelets and T cells play pivotal roles in TV development, the present study was conducted to assess the infl uence of NOD on development of TV in vivo.
Materials and Methods

N-octanoyl-dopamine synthesis
NOD was synthesized from commercially available precursors as previously described [31] . Briefl y, octanoic acid was dissolved in tetrahydrofuran and N-ethyldiisopropylamine before conversion to their mixed anhydride by the reaction with ethyl chloroformate. For coupling the crude mixed anhydride and dopamine hydrochloride were dissolved in N,N-dimethylformamide in the presence of diisopropylamine. Sodium hydrogen carbonate and sodium sulfi te were added and after evaporation of the solvent the product was obtained. The product was purifi ed by two-fold recrystallization from dichloremethane which was proved by thin layer chromatography. Samples were investigated by 1 H-NMR spectroscopy (Bruker AC250) and yielded spectra in accordance with the expected structure.
Rats
Male Dark Agouti (DA) and Brown Norway (BN) rats were obtained from Janvier 
Experimental groups
To study the infl uence of NOD on TV development, orthotopic aortic transplantation from DA to BN rats was performed. [36] . Rats were sacrifi ced after 2 or 4 weeks after transplantation and grafts were removed and processed for histological analyses as described below.
Aorta transplantation
Aortic allografts (10-12 mm) were transplanted as described previously [37] .
Briefl y, both donor and recipient rats received inhalation anesthesia (2% isofl uran/O 2 , fl ow 0.5 l/min). The abdominal aorta between the left renal artery and the bifurcation was removed from the donor rat and perfused with saline to remove blood cells. After 1 hour of cold storage in 0.9% saline at 4°C, the aortic graft was orthotopically transplanted into the recipient via end-to-end anastomosis using 9-0 nylon suture. Total warm ischemic time was consistently 25 minutes. Recipient rats received 0.05 mg/kg buprenorphine during surgery and at days 1 and 2 post-transplantation. No anti-rejection therapy was administered.
Quantitation of transplant vasculopathy
Grafts removed at autopsy were fi xed in formalin and embedded in paraffi n.
Tissue sections (3 µm) were taken from the center of each graft and were stained according Van Gieson to visualize elastin fi bers. Slides were scanned on a digital slide scanner (ScanScope CS2) and quantitated using ImageScope 11.2
(both Aperio, Vista, USA). Surface neointima was quantifi ed in nine sections from each graft: three sections cut at the center of the graft, and three sections cut 500 µm and 1000 µm distant hereof. Surface area NI was measured in 9 sections by subtracting lumen area from internal elastic lamina area. NI surface was normalized by dividing NI surface area by media surface area. For each graft the mean of all 9 sections was calculated.
Neointimal SMC proliferation in situ
To detect proliferating cells in aortic allografts (harvested 4 weeks after transplantation), immunohistochemistry for Ki67 and α-smooth muscle actin (αSMA) expression was performed on 3 µm sections from formalin-fi xed paraffi n embedded tissue. Heat-induced epitope retrieval (HIER) was performed in 10 mM citric acid (pH 6.0) for 15 min followed by endogenous peroxidase blockade using 0.3% H 2 O 2 in PBS. After rinsing in PBS, sections were incubated with rabbit-anti-human-Ki67 polyclonal antibody (clone NCL-Ki67p, Novocastra, Leica, Rijswijk, The Netherlands) for 1 hour. After rinsing in PBS sections were sequentially incubated with goat-anti-rabbit-HRP and rabbit-anti-goat-HRP (both Dako, Heverlee, Belgium). HRP-activity was visualized using 3,3′-diaminobenzidine (DAB). Sections were then incubated for another hour with mouse-anti-human-αSMA monoclonal antibody (clone 1A4, mIgG2a, Dako, Heverlee, Belgium) followed by incubation with rabbit-anti-mousealkaline phosphatase and stained using FastRed (Life Technologies, Bleiswijk,
The Netherlands). Sections were counterstained with Mayer's haematoxylin, coverslipped in Kaiser's glycerol-gelatin, scanned on a digital slide scanner (Nanozoomer 2.0HT, Hamamatsu, Almere, Netherlands) and analyzed using HistoQuest software (version 3.5.3.0171, TissueGnostics, Vienna, Austria).
To assess infl ammatory cell infi ltration, allografts (removed 2 weeks after transplantation) were analyzed for CD3 + and CD68 + cells. To this end, according the supplier's protocol. Fluorescence was assessed by fl ow cytometry and analyzed within 6 hours after fi nishing the staining protocol as described above.
Statistical analysis
Data is expressed as mean ± standard error of the mean (SEM). Statistical analysis was performed using Student's t-test with previous testing of normal distribution. A p-value of less than 0.05 was considered signifi cant.
Results
Neointima formation in aortic grafts
NI formation was assessed 4 weeks after transplantation in the vehicle-and NODtreated groups ( Figure 1A ). To this end, the total surface area of NI ( Figure 1B) as well as the normalized NI (NI/M ratio) ( Figure 1C ) was measured by morphometric analysis. At termination, 4 out of 7 animals in the NOD group showed either disconnected pumps or catheters. Therefore, the NOD group In B and C for each animal of each group serial section were made from the middle of the graft, and 500 and 1000 µm proximal hereof. For statistical analysis all sections were included (ITT: intention-to-treat; RT: received treatment).
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was analyzed either as intention-to-treat (ITT) (n=7, including all animals) or as received treatment (RT) (n=3, excluding rats with anticipated administration failure because of observed disconnections at sacrifi ce). Since it is unknown when the pumps or catheter got disconnected during follow-up, we cannot estimate the amount of NOD delivered i.v. in these animals. We consider these animals therefore as suboptimally treated. NOD-treatment showed a trend towards reduced NI formation in the ITT analysis when expressed as the total NI surface ( Figure 1B, left panel) . When expressed as NI/M ratio, neointima formation was signifi cantly reduced (p<0.05) in the NOD-treated rats ( Figure 1C , left panel).
After exclusion of the suboptimally treated rats, NOD-treatment showed a more pronounced reduction of NI formation as evidenced by a signifi cant reduction in absolute NI surface area (p<0.01, Figure 1B , right panel) and NI/M ratio (p<0.01, Figure 1C , right panel). The suboptimally treated rats indeed displayed more pronounced NI formation (not shown).
α-Smooth muscle actin expression and neointimal SMC proliferation in situ
We next assessed if NOD-treatment reduces the number of neointimal αSMA expressing cells and if in situ proliferation of these cells was affected. To this end, we fi rst validated in single stainings on paraffi n sections the method and antibody specifi city of anti-αSMA and anti-Ki67 antibodies (Figure 2A ). The antibodies appeared to be highly specifi c without cross-reactivity of secondary and tertiary antibodies (not shown). Next we performed double staining on allograft sections.
In contrast to isografts and non-transplanted aortas (not shown), in allografts a clear neointima was present composed of predominantly αSMA expressing cells ( Figure 2B ). In allografts αSMA expressing cells were hardly present anymore in the media, neither in vehicle-nor in NOD-treated rats ( Figure 2B ).
Quantitative analysis for αSMA and Ki67 was performed using HistoQuest morphometric analysis ( Figure 2C + αSMA + cells. D+E+F: For all grafts and for each group a total of 9 sections were evaluated. The sections were cut from the middle of the graft, and 500 and 1000 µm proximal hereof. For statistical analysis the mean of all sections was calculated (ITT: intention-to-treat; RT: received treatment).
Infl uence of NOD on T cell and macrophage infi ltration in aortic grafts
Since we have previously shown that in this aortic transplant model for evaluation of mononuclear cell infi ltration a two week follow-up was the optimal time point [37] , recipients were also sacrifi ced after 2 weeks. Tissue sections were stained for infi ltrating T cells and macrophages using anti-CD3 and anti-CD68 monoclonal antibodies, respectively (Figure 3 ).
Figure 3: NOD does not reduce CD3
+ T cell and CD68 + macrophage infi ltration. Infl ammation of aortic allografts was assessed 2 weeks after transplantation by immunohistology using anti-CD3 and anti-CD68 (ED-1) antibodies. A: Representative cross-sections of aortic allografts stained for T cells. B: Quantifi cation of infi ltrated T cells. C: Representative cross-sections of aortic allografts stained for macrophages. D: Quantifi cation of infi ltrated macrophages. B+D: Statistics were performed on 3 slides from the middle of the graft and 3 slides cut 500 µm further into the graft. Ratio of positive/total pixels of the whole section, containing NI, media and adventitia but excluding surrounding tissue, was assessed (ITT: intention-to-treat; RT: received treatment). (Figure 3A) , macrophages were present in both the adventitia and the subendothelial layer ( Figure 3C) . No difference in the degree of T cell infi ltration was found between vehicle-and NOD-treated groups, albeit that in RT analysis a trend towards a reduced number of T cells in NOD-treated rats was observed (p=0.09, Figure 3B ). Similarly, there was no difference between the groups with regard to macrophage infi ltration ( Figure 3D ).
Whereas T cells (CD3 +
) were predominantly found in the adventitia
NOD inhibits proliferation and apoptosis of SMC in vitro
Since proliferation (in NI) and apoptosis (in media) of SMC are critical events in NI formation we further investigated the infl uence of NOD on these parameters in vitro using cultured haSMC as described in the Methods section. Proliferation was assessed after 48 hours of stimulation and showed a clear inhibition by NOD ( Figure 4A ). Cell cycle analysis revealed accumulation of cells in the G1-phase ( Figure 4B ) suggesting that cell cycle progression was reduced by NOD. G1-arrest was further substantiated by qPCR, showing a signifi cant decrease in mRNA expression of AURKA, CCNA2, CCNB1 and CDK1, genes known to be involved in G1-progression ( Figure 4C ).
In addition to its effect on cell proliferation, it was also found that NOD inhibited 
Discussion
Inasmuch as in vitro studies have indicated that NOD inhibits the expression of endothelial cell adhesion molecules, leukocyte adhesion to the endothelium [33] and T cell activation [34] , the present study was conducted to assess if NOD has therapeutic effi cacy to reduce TV in a model of allogeneic aorta transplantation in rats. The following two major fi ndings were obtained in this study. Firstly, NOD signifi cantly attenuated NI formation assessed 4 weeks after transplantation.
Although this was associated with a reduction in the number of neointimal αSMA + cells, the proliferative state of these cells in situ was not affected. there is no direct experimental evidence that NOD impairs progenitor cell recruitment.
We previously described a strong anti-infl ammatory effect of NOD on endothelial cells [33] and T cells [34] . These observations were not confi rmed in the current study as NOD did not infl uence the degree of infi ltrated T cells and macrophages in vivo. However, only limited data is available for bioavailability and pharmacokinetics of NOD in vivo, and concentrations achieved in vivo might be far below from the concentrations used in vitro resulting in different cellular effects.
Beside cellular infl ammation also cytokines are recognized to play a pivotal role in vascular infl ammation. The relevance of cysteinyl leukotrienes (i.e. LTC4, LTD4)
in the pathogenesis of atherosclerosis was fi rst suggested by Porreca et al.
in a model of balloon catheter injury of the carotid artery in rats, where it was shown that a leukotriene D4 receptor antagonist provided effective inhibition of neointimal thickening [42] . More recent studies have further supported the role of leukotrienes in the pathogenesis of neointimal hyperplasia [43] [44] [45] .
Endogenous N-acyl-dopamines not only display anti-infl ammatory and immunomodulatory activities due to their propensity to inhibit NF-κB regulated gene expression [33, 46] , they were initially described as potent inhibitors of 5-lipoxygenase [47] . Although the synthetic N-acyl-dopamine NOD shares a number of biological activities with endogenous ones, further studies are warranted to assess if NOD also inhibits 5-lipoxygenase and if this may explain its benefi cial effect on TV in addition to its direct effects on SMC.
Apoptosis of medial SMC has been identifi ed as amplifi er for the development of TV as inhibition of SMC apoptosis was associated with a reduced NI formation [6] .
In vitro, NOD was able to suppress TNF-α-induced apoptosis, yet in vivo, loss of medial αSMA expression was noticed in aortic allografts from both untreated and NOD-treated rats. However, loss of αSMA expression could be linked to phenotypic modulation and not necessarily to apoptosis.
Chin et al. showed that metformin reduces I/R-injury and TV and suggested an AMP-activated protein kinase (AMPK) dependent mechanism that results in a lower apoptosis rate. We recently demonstrated that NOD activates AMPK [48] , yet both NOD and metformin can act as antioxidants [49] and therefore this precludes drawing fi rm conclusions as to whether the anti-apoptotic effect of both compounds are exclusively mediated via AMPK activation.
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In conclusion we demonstrate that NOD has a therapeutic effi cacy to reduce NI formation in a rat model of allogeneic aorta transplantation. Our in vitro data clearly support anti-apoptotic and anti-proliferative effects of NOD on SMC.
It remains to be shown that these benefi cial effects of NOD are solely responsible for the protective in vivo effects on the development of TV.
